Vinva Investment Management Ltd Reduces Stock Holdings in Universal Health Services, Inc. (NYSE:UHS)

Vinva Investment Management Ltd trimmed its stake in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 37.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 32,612 shares of the health services provider's stock after selling 19,486 shares during the period. Vinva Investment Management Ltd's holdings in Universal Health Services were worth $5,817,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Platinum Investment Management Ltd. boosted its stake in Universal Health Services by 17.6% during the fourth quarter. Platinum Investment Management Ltd. now owns 488 shares of the health services provider's stock worth $88,000 after buying an additional 73 shares during the period. Cozad Asset Management Inc. lifted its holdings in shares of Universal Health Services by 3.3% in the 4th quarter. Cozad Asset Management Inc. now owns 25,652 shares of the health services provider's stock worth $4,602,000 after acquiring an additional 815 shares during the last quarter. Cibc World Markets Corp boosted its stake in shares of Universal Health Services by 15.5% during the 4th quarter. Cibc World Markets Corp now owns 9,329 shares of the health services provider's stock worth $1,674,000 after purchasing an additional 1,250 shares during the period. Envestnet Portfolio Solutions Inc. bought a new position in Universal Health Services during the 4th quarter valued at about $564,000. Finally, Campbell Capital Management Inc. purchased a new stake in Universal Health Services in the 4th quarter worth about $46,000. Hedge funds and other institutional investors own 86.05% of the company's stock.

Remove Ads

Universal Health Services Stock Down 2.4 %

NYSE UHS traded down $4.21 during trading on Friday, reaching $174.49. 1,400,503 shares of the company's stock traded hands, compared to its average volume of 706,591. The company's 50 day simple moving average is $181.84 and its two-hundred day simple moving average is $198.83. Universal Health Services, Inc. has a 12-month low of $152.69 and a 12-month high of $243.25. The firm has a market cap of $11.34 billion, a price-to-earnings ratio of 11.60, a price-to-earnings-growth ratio of 0.53 and a beta of 1.32. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.39 and a quick ratio of 1.28.

Universal Health Services (NYSE:UHS - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported $4.92 EPS for the quarter, topping analysts' consensus estimates of $4.21 by $0.71. The company had revenue of $4.11 billion during the quarter, compared to the consensus estimate of $4.01 billion. Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. As a group, sell-side analysts forecast that Universal Health Services, Inc. will post 15.92 EPS for the current fiscal year.

Universal Health Services Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date was Monday, March 3rd. Universal Health Services's payout ratio is currently 4.75%.

Analyst Ratings Changes

UHS has been the topic of a number of analyst reports. Stephens upped their target price on Universal Health Services from $210.00 to $223.00 and gave the company an "equal weight" rating in a research note on Friday, February 28th. TD Cowen cut their price objective on Universal Health Services from $275.00 to $251.00 and set a "buy" rating on the stock in a research report on Tuesday, November 26th. Cantor Fitzgerald upgraded Universal Health Services from a "neutral" rating to an "overweight" rating in a research report on Monday, February 3rd. JPMorgan Chase & Co. reissued a "neutral" rating and set a $226.00 target price on shares of Universal Health Services in a research note on Tuesday, December 17th. Finally, Wells Fargo & Company reduced their price target on shares of Universal Health Services from $230.00 to $225.00 and set an "overweight" rating on the stock in a research note on Monday, March 10th. Six investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Universal Health Services has an average rating of "Moderate Buy" and a consensus target price of $230.75.

Insider Buying and Selling at Universal Health Services

In other news, Director Maria Ruderman Singer sold 1,000 shares of the firm's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $179.16, for a total value of $179,160.00. Following the sale, the director now directly owns 7,916 shares in the company, valued at approximately $1,418,230.56. This trade represents a 11.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 16.10% of the stock is owned by insiders.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.